Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model
Liposomes modified with a high concentration of polyethylene glycol (PEG) could
significantly prolong the retention time of the carried drug in the circulation, thus improving …
significantly prolong the retention time of the carried drug in the circulation, thus improving …
Pharmacokinetics and Dosimetry of 111In/188Re-Labeled PEGylated Liposomal Drugs in Two Colon Carcinoma-Bearing Mouse Models
PEGylated liposomes are important drug carriers for nanomedicine cancer therapy.
PEGylated liposomes can encapsulate radio-and chemo-drugs and passively target tumor …
PEGylated liposomes can encapsulate radio-and chemo-drugs and passively target tumor …
Evaluation of Pharmacokinetics of 111In-Labeled VNB-PEGylated Liposomes After Intraperitoneal and Intravenous Administration in a Tumor/Ascites Mouse Model
Nanoliposomes are important drug carriers that can passively target tumor sites by the
enhanced permeability and retention (EPR) effect in neoplasm lesions. This study evaluated …
enhanced permeability and retention (EPR) effect in neoplasm lesions. This study evaluated …
Influence of PEG coating on the biodistribution and tumor accumulation of pH-sensitive liposomes
SS Nunes, RS Fernandes, CH Cavalcante… - Drug delivery and …, 2019 - Springer
Liposomes are lipid vesicles widely used as nanocarriers in targeted drug delivery systems
for therapeutic and/or diagnostic purposes. A strategy to prolong the blood circulation time of …
for therapeutic and/or diagnostic purposes. A strategy to prolong the blood circulation time of …
Biodistribution and pharmacokinetics of 111In-DTPA-labelled pegylated liposomes in a human tumour xenograft model: implications for novel targeting strategies
KJ Harrington, G Rowlinson-Busza, KN Syrigos… - British journal of …, 2000 - nature.com
The biodistribution and pharmacokinetics of 111 In-DTPA-labelled pegylated liposomes in
tumour-bearing nude mice was studied to examine possible applications of pegylated …
tumour-bearing nude mice was studied to examine possible applications of pegylated …
[HTML][HTML] Co-encapsulation of chlorin e6 and chemotherapeutic drugs in a pegylated liposome enhance the efficacy of tumor treatment: Pharmacokinetics and …
PC Peng, RL Hong, T Tsai, CT Chen - Pharmaceutics, 2019 - mdpi.com
Long-circulating PEG-modified liposome has been shown to improve pharmacokinetic
properties and reduce systemic toxicity in cancer treatment. However, drug bioavailability …
properties and reduce systemic toxicity in cancer treatment. However, drug bioavailability …
[HTML][HTML] PEGylated versus non-PEGylated pH-sensitive liposomes: new insights from a comparative antitumor activity study
SS Nunes, J de Oliveira Silva, RS Fernandes… - Pharmaceutics, 2022 - mdpi.com
PEGylated liposomes are largely studied as long-circulating drug delivery systems.
Nevertheless, the addition of PEG can result in reduced interactions between liposomes and …
Nevertheless, the addition of PEG can result in reduced interactions between liposomes and …
Intra-tumor distribution of PEGylated liposome upon repeated injection: No possession by prior dose
H Nakamura, ASA Lila, M Nishio, M Tanaka… - Journal of Controlled …, 2015 - Elsevier
Liposomes have proven to be a viable means for the delivery of chemotherapeutic agents to
solid tumors. However, significant variability has been detected in their intra-tumor …
solid tumors. However, significant variability has been detected in their intra-tumor …
Effect of doxorubicin release rate from polyethylene glycol-modified liposome on anti-tumor activity in B16-BL6 tumor-bearing mice
M Maruyama, H Tojo, K Toi, Y Ienaka, K Hyodo… - Journal of …, 2022 - Elsevier
To investigate the effect of doxorubicin (DOX) release rates from polyethylene glycol (PEG)-
liposomes on the anti-tumor activity, several in-vitro and in-vivo studies were performed by …
liposomes on the anti-tumor activity, several in-vitro and in-vivo studies were performed by …
Enhanced retention and anti-tumor efficacy of liposomes by changing their cellular uptake and pharmacokinetics behavior
Although PEGylated liposome-based drug delivery systems hold great promising
applications for cancer therapy due to their prolonged blood circulation time, PEGylation …
applications for cancer therapy due to their prolonged blood circulation time, PEGylation …
Related searches
- polyethylene glycol therapeutic index
- pegylated liposomes biodistribution and pharmacokinetics
- pegylated liposome chemotherapeutic drugs
- pegylated liposome therapeutic efficacy
- pegylated liposome repeated injection
- pegylated liposomes targeting strategies
- pegylated liposomes 111in dtpa
- pegylated liposome tumor treatment
- pegylated liposome prior dose
- therapeutic efficacy chemotherapeutic drugs